Bullenkamp, J; Dinkla, S; Kaski, JC; Dumitriu, IE
(2016)
Targeting T cells to treat atherosclerosis: Odyssey from bench to bedside.
European Heart Journal - Cardiovascular Pharmacotherapy, 2 (3).
pp. 194-199.
ISSN 2055-6837
https://doi.org/10.1093/ehjcvp/pvw001
SGUL Authors: Dumitriu, Ingrid Elena
|
PDF
Published Version
Available under License Creative Commons Attribution. Download (268kB) | Preview |
Abstract
More than 150 years from the initial description of inflammation in atherosclerotic plaques, randomized clinical trials to test anti-inflammatory therapies in atherosclerosis have recently been initiated. Lymphocytes and macrophages are main participants in the inflammatory response in atherosclerosis. T lymphocytes operate mainly by exerting strong influences on the function of many cells in the immune system and beyond, and co-ordinating their interactions. Importantly, T lymphocytes are not a homogenous population, but include several subsets with specialized functions that can either promote or suppress inflammation. The interactions between these T-lymphocyte subsets have critical consequences on the course and outcome of inflammation. The complexity of the inflammatory response in atherosclerosis poses significant challenges on translating experimental findings into clinical therapies and makes the journey from bench to bedside an arduous one. Here, we summarize recent advances on the role of CD4 + T cells in the inflammatory process in atherosclerosis and discuss potential therapies to modulate these lymphocytes that may provide future breakthroughs in the treatment of atherosclerosis.
Item Type: | Article | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Additional Information: | © The Author 2016. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. | ||||||||||||
SGUL Research Institute / Research Centre: | Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) > Cardiac (INCCCA) |
||||||||||||
Journal or Publication Title: | European Heart Journal - Cardiovascular Pharmacotherapy | ||||||||||||
ISSN: | 2055-6837 | ||||||||||||
Publisher License: | Creative Commons: Attribution 4.0 | ||||||||||||
Projects: |
|
||||||||||||
URI: | https://openaccess.sgul.ac.uk/id/eprint/107719 | ||||||||||||
Publisher's version: | https://doi.org/10.1093/ehjcvp/pvw001 |
Statistics
Actions (login required)
![]() |
Edit Item |